GCP
PFE icon

Garda Capital Partners’s Pfizer PFE Stock Holding History

Garda Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,177
Closed -$2M – 653
2023
Q3 		$2M Buy
60,177
+9,000
+18% +$318K 0.09% 218
2023
Q2 		$1.88M Buy
51,177
+9,382
+22% +$365K 0.1% 194
2023
Q1 		$1.71M Buy
+41,795
New +$1.81M 0.08% 184

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Garda Capital Partners's PFE Position: Q4 2023 in Review

Garda Capital Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 60,177 shares — an estimated $2M sold.

Garda Capital Partners first reported a position in PFE in Q1 2023 and held it in 3 quarters. The position peaked at $2M in Q3 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Garda Capital Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Garda Capital Partners sold 60,177 Pfizer shares in Q4 2023, an estimated $2M.
  • Garda Capital Partners first reported a position in Pfizer in Q1 2023 and held it in 3 quarters.
  • Garda Capital Partners's Pfizer position peaked at $2M in Q3 2023.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Garda Capital Partners's 13F filing for Q4 2023, filed 12 Feb 2024.